Investors Land XENE Even Cheaper Than Its Secondary Stock Offering
January 20, 2022 at 16:54 PM EST
Looking back to 106 days ago, Xenon Pharmaceuticals Inc (XENE) priced a 8,474,577 share secondary stock offering at $29.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..